Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial.

Am J Respir Crit Care Med · 2021 · PMC7874409 · PMID 32757963

Europe PMC DOI

hedged sentence

0.2400

closest p · 4.8× alpha

0.2400

boldest claim

The sentences

did not reach statistical significanceP = 0.24not close (p > 0.1)

A trend for decreased 180-day mortality was shown in the PCT-guidance arm (30.4%) compared with SOC (38.2%), but it did not reach statistical significance (hazard ratio, 0.71; 95% CI, 0.42–1.19; P = 0.24).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.